Open AccessFrom Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer
Author(s) -
Deepa Rangachari,
Daniel B. Costa
Publication year - 2019
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.01207
Subject(s) - medicine , nivolumab , lung cancer , immune checkpoint , cancer , oncology , pembrolizumab , ipilimumab , immune system , pd l1 , immunotherapy , cancer research , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom